QIAGENಪರಿಶೀಲಿಸಿದ ಖಾತೆ

We had such interesting discussions and heard great presentations at #EUROGIN2018! Let's continue to work together to enable better outcomes for all women at risk for cervical cancer. See you at #EUROGIN2018!pic.twitter.com/qjs0D7KS3N

Before you leave #EUROGIN2018, find out how QIAGEN's comprehensive portfolio can improve your clinical management of the patients at risk for cervical cancer at booth 18.pic.twitter.com/T0GukTMrrc

Come talk with the makers of the very first FDA-approved HPV test for cervical cancer screening @ booth 18, #EUROGIN2018! Find out how you can use the most sensitive HPV test that has been evaluated in clinical trials involving more than 1 million women. http://fal.cn/r8hr pic.twitter.com/oRjs3mWzSN

It's our final day at #EUROGIN2018! Protect your patients and find out how QIAGEN's portfolio can give you results you can trust in assessing the risk for cervical cancer @ booth 18.pic.twitter.com/2Xqb6r62wW

Thanks for a great #ASH18 @ASH_hematology. We look forward to next years meeting in Orlando, Florida!pic.twitter.com/fpik7BLaEm

QCI Interpret, a complete solution for #NGS cancer test interpretation and reporting. Learn more at #ASH2018 booth # 1557. http://fal.cn/Sec1 pic.twitter.com/HdNHLMXSzV

Want a test to accurately determine HPV-positive patients’ risk of developing cervical cancer? Come talk to our specialists @ booth 18 at #EUROGIN2018 and learn more about the future of cervical cancer management: http://fal.cn/SenW pic.twitter.com/yEDcgvdkvO

CALR and JAK2 mutations now in WHO guidelines. Learn about QIAGEN blood cancer assays at booth #1557 at #ASH2018.  http://fal.cn/Se7A pic.twitter.com/nfZpvvDuKh

Trying to gain a complete view of the cancer mutational landscape? Find out how other labs have adopted an end-to-end NGS workflow, with automated bioinformatics. At booth #1557 at #ASH2018. http://fal.cn/SeIM pic.twitter.com/GgHe5Gcmwu

If you are looking for an adaptable, affordable high-risk HPV-test for limited-resource settings then visit us @ booth 18, #EUROGIN2018 to find out more about the WHO prequalified careHPV Test! http://fal.cn/SeHI pic.twitter.com/ZqEnFMRwLz

Did you know that the new QIAscreen HPV PCR Test is validated for physician-taken as well as self-collected samples? Talk to an expert @ booth 18, #EUROGIN2018 to find out more. http://fal.cn/SeLZ pic.twitter.com/ISJX4E8WrW

Sensitive, early detection of high-risk HPV with the digene test. Assess HPV and cervical cancer risk with confidence – Rediscover digene at #EUROGIN2018, booth 18: http://fal.cn/SeGG pic.twitter.com/6J9f5OFr0T

How can methylation biomarkers aid in the assessment of the risk cervical cancer? Talk with our experts at booth 18 at #EUROGIN2018 and learn more about the QIAsure test: http://fal.cn/Se0f pic.twitter.com/fobdhjLa0o

Don't miss your chance to have your questions about the newly WHO prequalified careHPV test answered at #EUROGIN2018, booth 18. http://fal.cn/SeJt pic.twitter.com/eXHlCg5oL4

Last chance to talk to a QIAGEN expert in person at #EUROGIN2018, booth 18, about the new QIAscreen test. Join us now! http://fal.cn/SeYj pic.twitter.com/pDM64CUlLT

Are you using the right test to determine whether an HPV infection is actively transforming cervical cells into cancer? Talk to our specialists @ booth 18, #EUROGIN2018 to find out. http://fal.cn/SeYL pic.twitter.com/Rb1U8131sC

It's now the 3rd day of #Eurogin2018! If you haven't had a chance yet, during your break between sessions, watch our video and come to booth 18 to talk to our QIAGEN experts about the latest cervical cancer screening innovations before the conference ends!pic.twitter.com/DuDr3oGOEK

Come to booth 18 at #EUROGIN2018 and explore a new HPV PCR solution with diverse menu options and a flexible workflow: http://fal.cn/SeTg pic.twitter.com/oGurJlEeGK